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Background
Detailed data concerning the distribution of patients with
schizophrenia across healthcare settings, their corre-
sponding use of healthcare resources and medication
received is limited. In this study, we aim to explore psychi-
atrists' perceptions of clinical practice across healthcare
settings in a sample of Greek psychiatric services.
Materials and methods
63 Psychiatrists (59 Private Practice, 4 University Hospi-
tals) completed structured anonymous questionnaires
between October - December 2006. Outcome measures
included disease burden, prescription and treatment pat-
terns for the management of schizophrenia.
Results
The distribution of patients treated in private practice ver-
sus hospital setting differs significantly across the three
phases of schizophrenia; acute (12% vs 5,3%), mainte-
nance (68,6% vs 60,42%) and relapse (19% vs 34,24%)
phase respectively (p<0.001), with hospitals demonstrat-
ing higher case severity ratings and inpatient average
length of stay of 52 days for first episode and 30 days for
management of relapse. Office-based psychiatrists present
a lower rate (17,8%) of dropouts, defined as patients insti-
tutionalized / hospitalized within the past year, as
opposed to clinic-based psychiatrists (31,2%), independ-
ently of case severity and visit frequency. Stable phase
patients on maintenance therapy are monitored more
closely in private than hospital practice (32 vs 49 days,
respectively). Psychiatrists perceived that conventional
and atypical antipsychotics are equally used as first-line
choice for acute cases, with a high rate of concomitant
antidepressants.
Conclusions
The distribution of patients and the prescription and treat-
ment patterns seem to be different across various health-
care settings, with prevailing of the private setting in the
management of acute phase and patient control, and the
hospitals in relapses.
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